Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Aronson JK"'
Autor:
Bahri P; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland. priya.bahri@ema.europa.eu.; European Medicines Agency (EMA) (Coordinator of the ISoP CommSIG in Her Personal Capacity), Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands. priya.bahri@ema.europa.eu., Bowring G; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; Uppsala Monitoring Centre (UMC), Uppsala, Sweden., Edwards BD; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; Husoteria Ltd, Ashtead, UK., Anton C; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; West Midlands Centre for Adverse Drug Reactions, City Hospital, Birmingham, UK., Aronson JK; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Oxford, UK., Caro-Rojas A; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; Pontificia Universidad Javeriana, Bogotá, Colombia., Hugman BPJ; Oxford, UK., Mol PG; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, The Netherlands., Trifirò G; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Ilic K; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; Takeda, Cambridge, MA, USA., Daghfous R; Tunisian National Centre of Pharmacovigilance, Tunis, Tunisia., Fermont I; Israel Society for Medication and Vaccine Safety (ERANIM), Jerusalem, Israel., Furlan G; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; Pfizer s.r.l., Safety Surveillance and Risk Management, Milan, Italy., Gaissmaier W; Department of Psychology, Social Psychology and Decision Sciences, University of Konstanz, Konstanz, Germany., Geer MI; Department of Pharmaceutical Sciences, University of Kashmir, Srinagar, India., Hartigan-Go KY; Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.; School of Government, Ateneo De Manila University, Quezon City, Philippines., Houÿez F; European Organisation for Rare Diseases (EURORDIS), Paris, France., Neth H; Department of Psychology, Social Psychology and Decision Sciences, University of Konstanz, Konstanz, Germany., Norgela G; Uppsala Monitoring Centre (UMC), Uppsala, Sweden., Oppamayun Y; Thai Food and Drug Administration, Health Product Vigilance Center, Bangkok, Thailand., Raynor DKT; School of Healthcare, University of Leeds, Leeds, UK., Bouhlel M; Tunisian National Centre of Pharmacovigilance, Tunis, Tunisia.; Department of Pharmacology, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia., Santoro F; Uppsala Monitoring Centre (UMC), Uppsala, Sweden., Sultana J; Pharmacy Department, Mater Dei Hospital, Msida, Malta.
Publikováno v:
Drug safety [Drug Saf] 2023 Jun; Vol. 46 (6), pp. 517-532. Date of Electronic Publication: 2023 May 23.
Autor:
Aronson JK; Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Publikováno v:
BMJ (Clinical research ed.) [BMJ] 2023 May 05; Vol. 381, pp. 1032. Date of Electronic Publication: 2023 May 05.
Autor:
Aronson JK; Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Publikováno v:
BMJ (Clinical research ed.) [BMJ] 2023 Apr 28; Vol. 381, pp. 980. Date of Electronic Publication: 2023 Apr 28.
Autor:
Aronson JK; Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Publikováno v:
BMJ (Clinical research ed.) [BMJ] 2023 Apr 14; Vol. 381, pp. 855. Date of Electronic Publication: 2023 Apr 14.
Autor:
Sartori D; Uppsala Monitoring Centre, Uppsala, Sweden. daniele.sartori@who-umc.org.; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. daniele.sartori@who-umc.org., Aronson JK; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Norén GN; Uppsala Monitoring Centre, Uppsala, Sweden., Onakpoya IJ; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Publikováno v:
Drug safety [Drug Saf] 2023 Feb; Vol. 46 (2), pp. 109-120. Date of Electronic Publication: 2022 Dec 05.
Autor:
Sartori D; Uppsala Monitoring Centre, Bredgränd 7B, 753 20, Uppsala, Sweden. daniele.sartori@who-umc.org., Aronson JK; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Woodstock Road, Oxford, OX2 6GG, United Kingdom., Onakpoya IJ; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Woodstock Road, Oxford, OX2 6GG, United Kingdom.
Publikováno v:
Systematic reviews [Syst Rev] 2020 Aug 13; Vol. 9 (1), pp. 180. Date of Electronic Publication: 2020 Aug 13.
Autor:
Aronson JK; Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, Oxford, UK jeffrey.aronson@phc.ox.ac.uk.; West Midlands Centre for Adverse Drug Reactions, City Hospital, Birmingham, UK., Goldacre B; Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, Oxford, UK., Ferner RE; West Midlands Centre for Adverse Drug Reactions, City Hospital, Birmingham, UK.; Institute of Clinical Sciences, University of Birmingham, UK.
Publikováno v:
BMJ (Clinical research ed.) [BMJ] 2018 Jul 24; Vol. 362, pp. k3141. Date of Electronic Publication: 2018 Jul 24.
Autor:
Onakpoya IJ; a University of Oxford, Centre for Evidence-Based Medicine , Nuffield Department of Primary Care Health Sciences , Oxford , UK., Heneghan CJ; a University of Oxford, Centre for Evidence-Based Medicine , Nuffield Department of Primary Care Health Sciences , Oxford , UK., Aronson JK; a University of Oxford, Centre for Evidence-Based Medicine , Nuffield Department of Primary Care Health Sciences , Oxford , UK.
Publikováno v:
Expert opinion on drug safety [Expert Opin Drug Saf] 2018 Jan; Vol. 17 (1), pp. 63-72. Date of Electronic Publication: 2017 Nov 01.
Autor:
Aronson JK; Department of Primary Care Health Sciences, New Radcliffe House, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, UK. jeffrey.aronson@phc.ox.ac.uk
Publikováno v:
Drug safety [Drug Saf] 2013 Mar; Vol. 36 (3), pp. 147-53.
Autor:
Aronson JK; Department of Primary Health Care, University of Oxford, Oxford, UK. jeffrey.aronson@phc.ox.ac.uk, Hauben M, Bate A
Publikováno v:
Drug safety [Drug Saf] 2012 May 01; Vol. 35 (5), pp. 347-57.